Oncotype Dx

Oncotype DX for Breast Cancer

Doctor Grew Explains Cancer

Role of the Oncotype DX Breast Recurrence Score Test

The role of the Oncotype DX assay in the management of patients with breast cancer

Oncotype DX – Do I Need a Breast Cancer Gene-Expression Assay?

Yerbba – Breast Cancer

Oncotype DX in Early Stage Breast Cancer

Oncotype DX testing to determine if a breast cancer patient will benefit from chemotherapy

Oncotype DX Breast Recurrence Score Assay after TAILORx and RxPONDER: What’s Next?

אונקוטסט

Oncotype DX for Early-stage Breast Cancer

Real-world use of OncotypeDx testing in the management of breast cancer in the North East

How the Oncotype DX Test Changed Treatment Decisions for 2 Women

Breast Cancer Answers®

Dr. Denduluri on the Use of the Oncotype DX Assay in Early-Stage HR+/HER2- Breast Cancer

Outcomes Matter -- oncotype DX®

Exact Sciences Precision Oncology

Genomic Testing in Breast Cancer: What You Must Know

Breast Cancer School for Patients

What does a low Oncotype DX® Recurrence Score® mean?

Breast Cancer Answers®

Dr. Katz on the Oncotype DX GPS Assay in Prostate Cancer

TAILORx: an update incl 12-year event rates in woman with ER+ lymph node-negative breast cancer

How do you communicate the Oncotype DX test results?

Breast Cancer Answers®

The Analytical and Clinical Validation of the Oncotype DX Breast Recurrence Score

Sociedad Peruana de Cancerología

Dr. Febbo Explains the Oncotype DX Genomic Prostate Score

RxPONDER: sparing chemotherapy in node-positive early-stage breast cancer